Author: Matthew Ettinger
-
Psilocybin Rescheduling
In the ongoing battle to enable access to psilocybin assisted therapy, a significant effort is focused on moving it off Schedule I of the Controlled Substances Act, which severely restricts its use to research purposes only. In February 2022, we collaborated with Dr. Aggarwal to petition the Drug Enforcement Administration (DEA) to reschedule psilocybin to…
